PHASE-II TRIAL OF MITOZOLOMIDE IN PATIENTS WITH ADVANCED OVARIAN-CANCER - A STUDY OF THE EORTC GYNECOLOGICAL CANCER COOPERATIVE GROUP

被引:6
作者
NEIJT, JP
VANDERBURG, MEL
GUASTALLA, JP
GEORGE, M
PICCART, M
VERMORKEN, J
CARNINO, F
ROTMENSZ, N
机构
[1] ROTTERDAM CANC INST,ROTTERDAM,NETHERLANDS
[2] FREE UNIV AMSTERDAM,1007 MC AMSTERDAM,NETHERLANDS
[3] CTR LEON BERARD,F-69373 LYONS 2,FRANCE
[4] INST GUSTAVE ROUSSY,F-94805 VILLEJUIF,FRANCE
[5] INST JULES BORDET,B-1000 BRUSSELS,BELGIUM
[6] EORTC DATA CTR,BRUSSELS,BELGIUM
[7] OSPED GINECOL SANTA ANNA,TURIN,ITALY
关键词
D O I
10.3109/02841868909092290
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:663 / 665
页数:3
相关论文
共 6 条
[1]  
[Anonymous], 1979, WHO HDB REPORTING RE
[2]  
FODSTAD O, 1985, CANCER RES, V45, P1778
[3]  
GIBSON NW, 1984, CANCER RES, V44, P1772
[4]   PHASE-II EVALUATION OF MITOZOLOMIDE IN OVARIAN-CANCER [J].
HARDING, M ;
NORTHCOTT, D ;
SMYTH, J ;
STUART, NSA ;
GREEN, JA ;
NEWLANDS, E .
BRITISH JOURNAL OF CANCER, 1988, 57 (01) :113-114
[5]  
JOSS RA, 1986, CANCER TREAT REP, V770, P797
[6]  
NEWLANDS ES, 1985, CANCER TREAT REP, V69, P801